Gallant Raises $18M for Vet Stem Cell Therapy
This is a San Diego news story, published by TechCrunch, that relates primarily to Gallant news.
San Diego news
For more San Diego news, you can click here:
more San Diego newsGallant news
For more Gallant news, you can click here:
more Gallant newsmedical innovations news
For more medical innovations news, you can click here:
more medical innovations newsTechCrunch news
For more news from TechCrunch, you can click here:
more news from TechCrunchAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like medical innovations news, you might also like this article about
human stem cell therapy. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest use stem cell therapy news, stem cells news, medical innovations news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Most stem cell treatments todayTechCrunch
•Health
Health
Ready-made stem cell therapies for pets could be coming | TechCrunch

84% Informative
San Diego startup Gallant announced $18 million in funding to bring the first FDA -approved ready-to-use stem cell therapy to veterinary medicine.
Gallant 's first target is a painful mouth condition in cats called Feline Chronic Gingivostomatitis ( FCGS ), which Gallant says could receive FDA approval by early 2026 .
VR Score
86
Informative language
86
Neutral language
52
Article tone
formal
Language
English
Language complexity
54
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
5
Source diversity
3
Affiliate links
no affiliate links